ESTANCMHealthcare·Medical Devices#25 in industry

Establishment Labs Holdings Inc.

Reports in 9d· 2026-05-06

+1.6% · 90d

$65.97

-0.32 (-0.48%)

News

(1)

April 2026

Apr 10, 20262 weeks agoDEF 14AHealthcare

ESTA Board Shrinks to Six as Founder Steps Down

ESTAESTABLISHMENT LABS HOLDINGS INC.

Here's a clear breakdown of Establishment Labs' (ESTA) 2026 Proxy Statement (DEF 14A), focusing on what shareholders need to know: # 🗳️ What This Document Is This is the **Definitive Proxy Statement (DEF 14A)** for Establishment Labs' **2026 Annual Shareholder Meeting**. It provides details on the

Read summaryView on SEC EDGAR

Key Data

Market Cap$1.94B

Open$66.47

Prev Close$66.28

Day Range$65.78 – $67.57

52W Range$28.89 – $83.31

Volume132,294

P/E (TTM)—

EPS$-1.72

Dividend Yield—

Beta1.08

Profit Margin-24.19%

Revenue Growth45.20%

Price Target$88.00(+33.4%)

Next Earnings2026-05-06(9d)

Analyst Ratings

Strong Buy9 analysts

Buy 8Hold 1Sell 0

About

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

Healthcare · Medical Devices

1,004 employees

www.establishmentlabs.com